BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.380
+0.110 (8.66%)
At close: Feb 27, 2026, 4:00 PM EST
1.354
-0.026 (-1.88%)
After-hours: Feb 27, 2026, 6:33 PM EST
BioVie Employees
BioVie had 13 employees as of June 30, 2025. The number of employees decreased by 1 or -7.14% compared to the previous year.
Employees
13
Change (1Y)
-1
Growth (1Y)
-7.14%
Revenue / Employee
n/a
Profits / Employee
-$1,344,472
Market Cap
10.41M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| KALA BIO | 38 |
| Imunon | 25 |
| Longeveron | 25 |
| SeaStar Medical Holding | 19 |
| Soligenix | 16 |
| Cardio Diagnostics Holdings | 15 |
| Akari Therapeutics, | 9 |
| Pulmatrix | 2 |
BIVI News
- 16 days ago - Halper Sadeh LLC Encourages BioVie Inc. Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewsWire
- 2 months ago - HALPER SADEH LLC ENCOURAGES BIOVIE INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 2 months ago - BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease Transcript - Seeking Alpha
- 3 months ago - Join Biovie's Exclusive Live Investor Webinar and Q&A Session on December 9 - GlobeNewsWire
- 5 months ago - BioVie Inc. - Special Call - Seeking Alpha
- 5 months ago - BioVie to Host Live Investor Webinar and Q&A on Oct. 8 - GlobeNewsWire
- 7 months ago - BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes - GlobeNewsWire
- 7 months ago - BioVie Inc. Announces Pricing of $12 Million Public Offering - GlobeNewsWire